Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors-Reference-Cited by-同舟云学术

Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors

Published:2021-03-02 Issue:4 Volume:15 Page:846-865
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Lobo João¹²³⁴^ORCID,Constâncio Vera¹^ORCID,Guimarães‐Teixeira Catarina¹^ORCID,Leite‐Silva Pedro¹^ORCID,Miranda‐Gonçalves Vera¹^ORCID,Sequeira José Pedro¹^ORCID,Pistoni Laura¹⁵,Guimarães Rita¹²,Cantante Mariana¹²,Braga Isaac⁶^ORCID,Maurício Joaquina⁷,Looijenga Leendert H. J.⁴^ORCID,Henrique Rui¹²³^ORCID,Jerónimo Carmen¹³^ORCID

Affiliation:

1. Cancer Biology and Epigenetics Group IPO Porto Research Center (GEBC CI‐IPOP) Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (PCCC) Portugal

2. Department of Pathology Portuguese Oncology Institute of Porto (IPOP) Portugal

3. Department of Pathology and Molecular Immunology Institute of Biomedical Sciences Abel Salazar University of Porto (ICBAS‐UP) Portugal

4. Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands

5. Department of Biology University of Pisa Italy

6. Department of Urology Portuguese Oncology Institute of Porto (IPOP) Portugal

7. Department of Medical Oncology Portuguese Oncology Institute of Porto (IPOP) Portugal

Funder

Fundação para a Ciência e a Tecnologia

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology